Browse Related Topics For:

Pharmaceutical Industry The United States Food and Drug Administration

337
Prescription Drugs
185
Biosimilars
176
Generic Drugs
157
Patents
143
Pharmaceutical Patents
142
Medical Devices
101
BPCIA
100
Off-Label Promotion
98
Patent Infringement
98
Patent Litigation
97
ANDA
90
Healthcare
81
Biologics
75
FDCA
75
Hatch-Waxman
70
First Amendment
61
Sandoz
59
Labeling
58
Amgen
57
Popular
53
Off-Label Use
51
Draft Guidance
51
Manufacturers
46
Sandoz v Amgen
44
Amarin
41
SCOTUS
39
HHS
37
FDA Approval
37
Preemption
36
Clinical Trials
35
Free Speech
35
Medicare
33
Affordable Care Act
32
Life Sciences
31
FTC
31
Medicaid
31
Misbranding
30
Advertising
30
Marketing
29
21st Century Cures Initiative
29
Preliminary Injunctions
28
Drug Compounding
28
Pharmacies
26
Failure To Warn
26
Health Care Providers
24
CMS
24
Commercial Speech
24
Warning Labels
22
Appeals
20
Biotechnology
20
False Claims Act (FCA)
20
Patent-in-Suit
20
Product Labels
19
DOJ
19
NIH
18
Drug Safety
18
Patent Dance
17
Commercial Marketing
17
Enforcement Actions
17
Medical Research
16
AbbVie
16
aBLA
16
Apotex
16
Biologics Price Competition and Innovation Act of 2009
16
Comment Period
16
Drug Pricing
16
Physicians
15
New Guidance
15
Orphan Drugs
15
Safe Harbors
15
Social Media
14
Antitrust Litigation
14
Caronia
14
Citizen Petitions
14
Class Action
14
Corporate Counsel
14
Hospitals
14
Mylan Pharmaceuticals
14
Patent Applications
13
FFDCA
13
Final Guidance
13
Final Rules
13
Johnson & Johnson
13
Reverse Payment Settlement Agreements
13
Settlement
12
DSCSA
12
EU
12
Healthcare Reform
12
Notice Requirements
12
OIG
12
PHRMA
12
Proposed Regulation
12
Public Health Service Act
12
Summary Judgment
12
Teva Pharmaceuticals
11
Declaratory Judgments
11
DQSA
11
GlaxoSmithKline
11
Legislative Agendas
11
Research and Development
11
SEC
10
Bayer
10
Discovery
10
Enforcement
10
FTC v Actavis
10
Hospira
10
Multidistrict Litigation
10
PLIVA v Mensing
10
Product Exclusivity
10
Professional Conferences
10
Supply Chain
10
Warning Letters
9
Civil Monetary Penalty
9
Health Insurance
9
HIPAA
9
Innovation
9
Personal Jurisdiction
9
Pfizer
9
Proposed Legislation
9
Reporting Requirements
9
Social Networks
9
Trump Administration
9
USPTO
8
3D Printing
8
Actavis Inc.
8
Antitrust Violations
8
Criminal Prosecution
8
Drug Approvals
8
False Advertising
8
Fraud
8
Intellectual Property Protection
8
Medicare Part D
8
Misleading Statements
8
Orange Book
8
Pending Legislation
8
Prior Art
8
Public Comment
8
Public Meetings
8
Section 340B
8
Trademarks
8
Whistleblowers
7
Adverse Events
7
Cancer
7
CDC
7
Disclosure Requirements
7
Drug Distribution
7
HRSA
7
Janssen Pharmaceuticals
7
Merck
7
Motion to Dismiss
7
Obviousness
7
Opioid
7
PHSA
7
Product Hopping
7
Public Health
7
Qui Tam
7
Regulatory Standards
7
REMS
7
Side Effects
7
Watson Pharmaceuticals
6
Abbott Laboratories
6
Barack Obama
6
Birth Defects
6
Certiorari
6
Compliance
6
Congressional Investigations & Hearings
6
Design Defects
6
Federal Funding
6
FOIA
6
GAO
6
Health Information Technologies
6
Informed Consent
6
Inter Partes Review (IPR) Proceeding
6
Novartis
6
Otsuka Pharmaceutical
6
Patent Invalidity
6
Pay-For-Delay
6
Pleading Standards
6
Product Defects
6
Public Hearing
6
Scientific Research
6
Securities Fraud
6
Sherman Act
6
Standing
6
Websites
6
World Health Organization
5
21st Century Cures Act
5
Administrative Procedure Act
5
Allergan Inc
5
Anti-Competitive
5
Anti-Kickback Statute
5
Black Box Warnings
5
Brand
5
Canada
5
Causation
5
Celebrity Endorsements
5
CHIP
5
Competition
5
Cybersecurity
5
DEA
5
Diagnostic Tests
5
Eli Lilly
5
European Medicines Agency (EMA)
5
Exclusivity
5
Expert Testimony
5
Federal Rule 12(b)(6)
5
Federal Rules of Civil Procedure
5
Fifth Amendment
5
HCEI
5
Illegal Drugs
5
Infringement
5
Injunctive Relief
5
Interchangeability
5
Jurisdiction
5
Learned Intermediary
5
Medicare Part B
5
Medtronic
5
Mergers
5
Negligence
5
OMB
5
Personalized Medicine
5
Securities Litigation
5
Unfair Competition
5
Unfair or Deceptive Trade Practices
5
USDA
4
Advisory Committee
4
America Invents Act
4
Antitrust Provisions
4
Big Data
4
Boehringer
4
CGMP
4
Claim Construction
4
Class Certification
4
Classen Immunotherapies
4
Databases
4
Dietary Supplements
4
DNA
4
Durable Medical Equipment
4
Elan Pharmaceuticals
4
Endo Pharmaceuticals
4
EPA
4
FCPA
4
FDA Warning Letters
4
FDASIA
4
Healthcare Fraud
4
Home Health Care
4
Inadequate Warning
4
Insider Trading
4
IRS
4
Kickbacks
4
Kim Kardashian
4
Legislative Committees
4
Licenses
4
Long Term Care Facilities
4
MedPAC
4
Mental Health
4
Misleading Impressions
4
Monopolization
4
New Legislation
4
No-AG Agreement
4
OPDP
4
Outsourcing
4
OxyContin
4
Patients
4
PDUFA
4
Pregnancy
4
Product Recalls
4
Regulatory Oversight
4
Samsung
4
Shareholders
4
Substance Abuse
4
Technology
4
UAW
3
510(k) RTA
3
Acquisitions
3
Allergan v Sandoz
3
Biogen Idec
3
Biopharmaceutical
3
Burden of Proof
3
CEOs
3
Chevron Deference
3
China
3
Contraceptives
3
Controlled Substances Act
3
Covered Entities
3
Data Protection
3
Daubert Standards
3
Declaratory Relief
3
Disgorgement
3
Dismissals
3
EHR
3
Employee Benefits
3
Exclusive Dealing Agreements
3
False Statements
3
FD&C Act
3
Federal Register
3
Financial Conduct Authority (FCA)
3
Financial Markets
3
Food Recalls
3
Foreign Manufacturers
3
Generic
3
Genzyme
3
Google
3
Healthcare Facilities
3
Innovator Liability
3
Intellectual Property Litigation
3
Internet
3
Inventors
3
Investigational New Drug Application (IND)
3
IRB
3
Laboratory Developed Tests
3
Lanham Act
3
License Agreements
3
Medical Malpractice
3
Medicare Advantage
3
Mutual Pharmaceuticals v Bartlett
3
Notice Provisions
3
On-Sale Bar
3
openFDA
3
Pain Management
3
Patent Trial and Appeal Board
3
Patent-Eligible Subject Matter
3
Patient Privacy Rights
3
Patient Safety
3
Permanent Injunctions
3
Premarket Approval Applications
3
Prescription Drug Coverage
3
Private Right of Action
3
PSLRA
3
Public Disclosure
3
Public Health Insurance Marketplace
3
Purple Book
3
Putative Class Actions
3
Quality Control Plan
3
Regulatory Agenda
3
Risk Assessment
3
Risk Management
3
Rule-of-Reason Analysis
3
Sealed Records
3
Secretary of HHS
3
Securities
3
Settlement Agreements
3
SNDAs
3
Software
3
Strategic Enforcement Plan
3
Subject Matter Jurisdiction
3
Sunshine Act
3
Takeda Pharmaceuticals
3
Tax Credits
3
Telemedicine
3
Trade Secrets
3
Transparency
3
Twitter
3
Verification Requirements
3
Veterinary Products
3
Wholesale
3
Wyeth
2
ACOs
2
All Writs Act
2
American Medical Association
2
Amgen v Sandoz
2
Amicus Briefs
2
AMP v Myriad
2
Animal Drugs
2
Animal Testing
2
Antibiotics
2
Antitrust Injuries
2
Article III
2
AstraZeneca
2
Attorney Generals
2
Attorney-Client Privilege
2
Audits
2
Bifurcation
2
Biometric Information
2
Bristol-Myers Squibb
2
Celltrion
2
Center for Drug Evaluation and Research (CDER)
2
Cephalon
2
Chemicals
2
Clear and Convincing Evidence
2
Clinical Laboratories
2
Combination Products
2
Confidential Information
2
Conflicts of Interest
2
Controlled Substances
2
Conversion
2
Corporate Integrity Agreement
2
Cosmetics
2
Counterclaims
2
Counterfeit Drugs
2
Daiichi Sankyo
2
DaimlerChrysler v Bauman
2
Data Breach
2
Disclaimers
2
Diversity Jurisdiction
2
DMEPOS
2
Drug & Alcohol Abuse
2
Due Process
2
Duty to Deal
2
Ethics
2
Evidence
2
Exemptions
2
Expert Witness
2
Failure To Disclose
2
Federal Health Care Programs (FHCP)
2
Federal Question Jurisdiction
2
Financial Sector
2
First Impression
2
First-to-File
2
Food and Drug Administration Amendments Act (FDAAA)
2
Fraudulent Joinder
2
FSMA
2
GDUFA
2
General Jurisdiction
2
Genetic Testing
2
Gilead Sciences
2
Government Investigations
2
GPOs
2
Guidance Update
2
Hackers
2
Health Insurance Exchanges
2
Health Safety
2
HITECH
2
HIV
2
Human Rights
2
Imports
2
Induced Infringement
2
Injunctions
2
Inpatient Prospective Payment System (IPPS)
2
Inspections
2
Insurance Industry
2
Internal Controls
2
International Arbitration
2
Internet Marketing
2
Interstate Commerce
2
Investigational Device Exemptions
2
Investigational New Drug procedures (IND)
2
Investors
2
IP License
2
Licensing Rules
2
Manufacturing Defects
2
Marijuana
2
Medicaid Expansion
2
Medical Reimbursement
2
Mensing
2
Mental Health Parity Rule
2
Method Claims
2
Misrepresentation
2
Mobile Apps
2
Mootness
2
National Cancer Moonshot
2
Native American Issues
2
Nike
2
OCR
2
Omissions
2
Omnibus Guidance
2
Omnicare
2
Omnicare v Laborers District Council
2
Online Advertisements
2
Outsourcing Facilities
2
Over-the-Counter Sales
2
Pay-Per-Click
2
PCORI
2
Personally Identifiable Information
2
Petition for Writ of Certiorari
2
POM Wonderful
2
Post-Grant Review
2
Presidential Elections
2
Price Gouging
2
Qualified Small Employer Health Reimbursement Plan (QSEHRAs)
2
RanBaxy
2
Registration Requirement
2
Regulatory Reform
2
Reimbursements
2
Relators
2
Reverse Payments
2
Right to Try
2
Ripeness
2
Rulemaking Process
2
Safety Precautions
2
Sanctions
2
Sanofi
2
Schering-Plough
2
Scientific Evidence
2
Search Engines
2
Section 503
2
Securities Exchange Act
2
Securities Violations
2
Skilled Nursing Facility
2
Solicitor General
2
Spectrum
2
Stark Law
2
Startups
2
Statute of Limitations
2
Stem cells
2
Stock Drop Litigation
2
Strict Liability
2
Subsidies
2
Tax Deductions
2
Telehealth
2
The Common Rule
2
Transfer of Venue
2
TRO
2
Two-Midnight Rule
2
Twombly/Iqbal Pleading Standard
2
UK
2
User-Generated Content
2
Venture Capital
2
Warner Chilcott
2
Webinars
2
Written Descriptions
2
Wrongful Death
2
Young Lawyers
1
35 U.S.C. § 271(e)(1)
1
Acceleration
1
Accounting Controls
1
Actos
1
Actual Injuries
1
Addiction Equity Act
1
Additive Manufacturing
1
Administrative Authority
1
Administrative Proceedings
1
Admissible Evidence
1
Advance Notice
1
Advisory Opinions
1
Aerospace
1
AHRQ
1
AIDS
1
AIG
1
ALJ
1
All Natural
1
Alzheimer's
1
Amazon
1
Ambulatory Surgery Centers
1
Amended Complaints
1
Amended Regulation
1
Amgen Inc. v Connecticut Retirement Plans
1
Amgen v Apotex
1
Animal Food
1
Animal Health
1
Anti-Monopoly
1
Anti-Retaliation Provisions
1
Anti-Steering Rules
1
Antimicrobials
1
Antitrust Conspiracies
1
App Developers
1
Applicable Manufacturers
1
Applications
1
Appointments Clause
1
Appropriate Equitable Relief
1
Arbitration
1
Article II
1
Artificial Intelligence
1
Asbestos
1
Asbestos Litigation
1
Assignments
1
Attestation Deadlines
1
Automobile Recall
1
Automotive Industry
1
Bank of New York (BNY) Mellon
1
Banking Sector
1
Barclays
1
Bayh-Dole Act
1
Benefit Plan Reimbursements
1
Best Buy
1
Best Management Practices
1
Best Practices
1
Billing
1
Bilski
1
Bipolar Disorder
1
Birth Control Pill
1
Boston Scientific
1
BPCI
1
Brand Name Prescription Drugs
1
Breakthrough Therapy Designation
1
Business Associates
1
Business Development
1
C&DIs
1
CA Supreme Court
1
CAFC
1
Canadian Intellectual Property Office
1
Cartwright Act
1
Carve Out Provisions
1
Caterpillar
1
CCIIO
1
CERCLA
1
CFPB
1
Chief Compliance Officers
1
Childrens' Motrin
1
Chilling Effect
1
Chip and PIN
1
Cipro
1
Citizen Suits
1
Claim Preclusion
1
Clean Air Act
1
Clean Water Act
1
clear
1
Clearance
1
CLIA
1
Climate Action Plan
1
Clinical Laboratory Testing
1
CLS Bank v Alice Corp
1
CMMI
1
Co-payments
1
COBRA
1
Coca Cola
1
Commerce Clause
1
Commitment Letter
1
Common Law Claims
1
Community Health Systems
1
Compensation & Benefits
1
Compensatory Awards
1
Compensatory Damages
1
Competitive Bidding
1
Complete Genomics
1
Comptroller of the Treasury v Wynne
1
Confidential Documents
1
Conflicting Proposals
1
Congressional Committees
1
Congressional Review Act
1
Consent Decrees
1
Constitutional Challenges
1
Consumer Fraud
1
Consumer Product Safety Commission (CPSC)
1
Consumer Protection Act
1
Consumers Legal Remedies Act
1
Contamination
1
Contests & Promotions
1
Continuing Medical Education
1
Contraceptive Coverage Mandate
1
Contract Drafting
1
Contributory Infringement
1
Copyright
1
Corporate Misconduct
1
Corporate Taxes
1
Corrective Actions
1
Corruption
1
Cost-Sharing
1
Costco
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Covered Recipients
1
CPUC
1
CREATE Act
1
Credibility
1
Cross Motions
1
Cross-Border Transactions
1
Crowdfunding
1
Cruel & Unusual Punishment
1
Cuozzo Speed Technologies v Lee
1
Customs and Border Protection
1
CVM
1
Cyber Attacks
1
Cyber Threats
1
DaimlerAG
1
Data Controller
1
Data Integrity
1
Data Mining
1
Data Security
1
De Minimis Claims
1
De Novo Standard of Review
1
Debit and Credit Card Transactions
1
Deceptive Intent
1
Defect
1
Defense Strategies
1
Delaware General Corporation Law
1
Delays
1
Department of Transportation (DOT)
1
Department of Veterans Affairs
1
Derivation Proceeding
1
Device Classification
1
DHS
1
Diagnostic Imaging Services
1
Diagnostic Method
1
Digital Health
1
Direct Infringement
1
Direct Purchasers
1
Direct to Consumer Sales
1
Dirks v SEC
1
Disability Discrimination
1
Disclosure
1
Discounts
1
Discussion Draft
1
Disruptive Technology
1
Distributors
1
Document Retention Policies
1
Dodd-Frank
1
DOL
1
Double Jeopardy
1
Drug Testing
1
Drug Treatment
1
DSHEA
1
Duty to Warn
1
E-Filing
1
EAR
1
Earn-Outs
1
EEOC
1
Eighth Amendment
1
Electronic Communications
1
Electronic Filing
1
Electronic Health Record Incentives
1
Electronic Records
1
Electronically Stored Information
1
Eleventh Amendment
1
Email
1
Embargo
1
Emerging Markets
1
Employer Group Health Plans
1
Employer Mandates
1
En Banc Review
1
Environmental Policies
1
ERISA
1
Ernst & Young
1
EU-US Privacy Shield
1
European Food Safety Authority (EFSA)
1
Events
1
Evidence Suppression
1
Evidentiary Standards
1
Ex Post Facto Clause
1
Excessive Pricing
1
Excise Tax
1
Executive Orders
1
Expedited FDA Approval
1
Export Controls
1
Exports
1
Extrapolation
1
Failure To State A Claim
1
Fair Notice
1
False Evidence
1
False Press Release
1
Falsified Documents
1
Fast Track Process
1
FBI
1
FCC
1
Federal Budget
1
Federal Rule 12(b)(1)
1
Federal v State Law Application
1
FedEx
1
Fee-for-Service
1
Fee-Shifting
1
Fiduciary Duty
1
Fiduciary Rule
1
Financial Institutions
1
Flame Retardant
1
Flexible Spending Accounts
1
FMCSA
1
Food Labeling
1
Food Poisoning
1
Foreign Corporations
1
Foreign Earned Income
1
Foreign Tax
1
Foreseeability
1
Form 10-K
1
Form 8-K
1
Forum Shopping
1
Fraud-on-the-Market
1
FRCP 26
1
FSMB
1
FTC Act
1
Funding
1
Genentech
1
General Electric
1
General Services Administration (GSA)
1
General Wellness Devices
1
Genetic Materials
1
Goldman Sachs
1
Good Cause
1
Good Clinical Practices
1
Goodyear
1
Government Studies
1
Grable Factors
1
Grocery Stores
1
gTLD
1
Guilty Pleas
1
Halliburton v Erica P. John Fund
1
Hazardous Substances
1
Hazardous Waste
1
HCPCS
1
Health Canada
1
Health Care Violations
1
Health IT
1
Health Savings Accounts
1
Healthcare Costs
1
Hedge Funds
1
HELP
1
Hewlett-Packard
1
Hoffman LaRoche
1
Home Depot
1
Homeopathic Remedies
1
Honeybees
1
Hospice
1
Hospital Mergers
1
HRA
1
Human Genome Project
1
ICD-10
1
Illegal Tipping
1
Implied Certification
1
In-Person Exam
1
Incentives
1
Income Taxes
1
Indictments
1
Indirect Infringement
1
Individual Mandate
1
Infectious Diseases
1
Information Reports
1
Information Sharing
1
Initial Public Offerings
1
Inpatient Rehab Facilities
1
Integra
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Interest Rate Adjustments
1
Interest Rates
1
InterMune
1
International Harmonization
1
Internet of Things
1
Internet Retailers
1
INTERPOL
1
Interpretive Rule
1
Inventions
1
Investment
1
Investment Adviser
1
Investment Advisers Act of 1940
1
Investment Trust Companies
1
IRF Claim Processing
1
JAMA
1
Janus Capital Group
1
Joinder
1
Joint Venture
1
Journalists
1
Judicial Review
1
Jury Awards
1
Jury Trial
1
Justiciable Controversy
1
King v Burwell
1
KPMG
1
LabMD
1
Law Enforcement
1
Leave to Amend
1
Legal History
1
Legal Perspectives
1
License Applications
1
Lipitor
1
Litigation Hold
1
Litigation Privilege
1
Lobbyists
1
Local Ordinance
1
Loss Causation
1
MA Supreme Court
1
Managed Care Contracts
1
Manufacturing Facilities
1
Marijuana Cultivation
1
Marijuana Related Businesses
1
Market Manipulation
1
Market Research
1
Marketing Authorization Application
1
MasterCard
1
Material Misrepresentation
1
Material Misstatements
1
MCOs
1
Medical Foods
1
Medical Liability
1
Medical Supplies
1
Medicare Access and CHIP Reauthorization (MACRA)
1
Medicare Modernization Act
1
Medicare Prescription Drug Improvement and Modernization Act (MMA)
1
Memorandum of Understanding
1
Mental Health Initiatives
1
Merrill Lynch v Manning
1
Methane
1
Minor Children
1
Motion for Reconsideration
1
Motion To Centralize
1
Motion to Remand
1
Motion To Stay
1
Motor Carriers
1
NAD
1
NAFTA
1
Nanomedicine
1
Nanotechnology
1
Natural Products
1
Negligence Per Se
1
Negligent Design
1
New Regulations
1
New Trial
1
Nexus
1
NJ Supreme Court
1
Non-Practicing Entities
1
Non-Public Information
1
Notice of Appeal
1
Notifications
1
NPRM
1
Numerosity
1
Nursing Homes
1
Obama Administration
1
OECD
1
OEHHA
1
OFAC
1
Off-Campus Departments
1
Office of Scientific Investigations (OSI)
1
OFVM
1
Oil & Gas
1
ONC
1
Online Platforms
1
Online Reviews
1
Open Enrollment
1
OPPS
1
Opt-Outs
1
Out-of-State Companies
1
Out-of-State Judgments
1
Overpayment
1
Par Pharmaceutical
1
Parallel Claims
1
Partnerships
1
PATENT Act
1
Patent Cooperation Treaty
1
Patent Exhaustion
1
Patent Expiration
1
Patent Filings
1
Patent Portfolios
1
Patent Reform
1
Patent Term Extensions
1
Patent-Misuse
1
Patient Assistance Programs
1
Patient Prospective Payment System
1
Patient-Specific
1
Pay or Play
1
Pay Ratio
1
Pay Ratio Tax
1
Payment Records
1
Payor Contracts
1
Payroll Taxes
1
Pediatrics
1
Penalties
1
Pension Funds
1
Pensions
1
Personal Benefit
1
Personal Care Products
1
Personal Liability
1
Pesticides
1
Pharmaceutical Distribution
1
Pharmacist
1
PHH Corp. v CFPB
1
Planned Parenthood
1
Podcasts
1
POM Wonderful v Coca Cola
1
Post-Market Approval
1
Posting Requirements
1
Pradaxa
1
Precision Medicine Initiative (PMI)
1
Price Transparency
1
Price-Fixing
1
Primary Jurisdiction Doctrine
1
Prior User
1
Prioritized Examination
1
Prison
1
Privacy Laws
1
Privacy Policy
1
Privately Held Corporations
1
Privilege Logs
1
Product Enhancements
1
Professional Liability
1
Professional Misconduct
1
Profits
1
Prometheus
1
Proposed Amendments
1
Proposed Rules
1
Protective Orders
1
Psychiatric Hospitals
1
PTAC
1
Public Access Laws
1
Public Notice
1
Public Performance Rights
1
Public Safety
1
Publicly-Traded Companies
1
RCRA
1
Rebates
1
Recordkeeping Requirements
1
Reed v Town of Gilbert
1
Registration
1
Regulation S-K
1
Regulatory Agencies
1
Regulatory Burden
1
Release of Information
1
Remand
1
Remedies
1
Removal For-Cause
1
Reorganizations
1
Repeal
1
Required Communications
1
Required Documentation
1
Res Ipsa Loquitur
1
Research Funding
1
RESPA
1
Restitution
1
Restraining Orders
1
Retailers
1
Retaliation
1
Reversal